Literature DB >> 11929421

Lack of association between atopic eczema/dermatitis syndrome and polymorphisms in the promoter region of RANTES and regulatory region of MCP-1.

G T Kozma1, A Falus, A Bojszkó, D Krikovszky, T Szabó, A Nagy, C Szalai.   

Abstract

BACKGROUND: Chemokines play an important role in the pathophysiology of atopic eczema/dermatitis syndrome (AEDS) and allergy. Recently polymorphisms in the promoter region of RANTES (regulated on activation normal T cell expressed and secreted) and in the gene regulatory region of MCP-1 (monocyte chemoattractant protein-1) have been found, which increase the expression of these chemokines. The - 403A allele of the RANTES promoter region was found associated with AEDS in German children. We investigated whether the presence of these polymorphisms was associated with AEDS or allergy in Hungarian children.
METHODS: One hundred and twenty-eight children with AEDS, 102 allergic children without AEDS and 303 children of comparable ages without allergic disorders were screened for genotype with a PCR-based assay.
RESULTS: There were no significant differences in the frequency of these polymorphisms, or in the distribution of genotypes between the groups. The total IgE concentration, the white blood cell count and the blood eosinophil cell count did not differ between the genotypes.
CONCLUSION: In this cohort of Hungarian children there was no association between - 28G, and - 403A alleles in the RANTES promoter, - 2518G polymorphism in the distal regulatory region of the MCP-1 and AEDS, or allergy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929421     DOI: 10.1034/j.1398-9995.2002.1s3361.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  7 in total

1.  [Genetics of common chronic inflammatory skin diseases : An update on atopic dermatitis and psoriasis].

Authors:  E Rodríguez; K Eyerich; S Weidinger
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

Review 2.  The genetics of atopic dermatitis: recent findings and future options.

Authors:  Sabine Hoffjan; Jörg T Epplen
Journal:  J Mol Med (Berl)       Date:  2005-05-18       Impact factor: 4.599

Review 3.  The genetics of atopic dermatitis.

Authors:  Yin-Hsiu Chien; Wuh-Liang Hwu; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2007-12       Impact factor: 8.667

Review 4.  CCL5 as a potential immunotherapeutic target in triple-negative breast cancer.

Authors:  Dandan Lv; Yan Zhang; Ha-Jeong Kim; Lixing Zhang; Xiaojing Ma
Journal:  Cell Mol Immunol       Date:  2013-02-04       Impact factor: 11.530

Review 5.  Molecular Genetic of Atopic dermatitis: An Update.

Authors:  Hani A Al-Shobaili; Ahmed A Ahmed; Naief Alnomair; Zeiad Abdulaziz Alobead; Zafar Rasheed
Journal:  Int J Health Sci (Qassim)       Date:  2016-01

6.  The rs1024611 regulatory region polymorphism is associated with CCL2 allelic expression imbalance.

Authors:  Minh-Hieu T Pham; Gregory B Bonello; John Castiblanco; Tuan Le; Jose Sigala; Weijing He; Srinivas Mummidi
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

Review 7.  Association studies for asthma and atopic diseases: a comprehensive review of the literature.

Authors:  Sabine Hoffjan; Dan Nicolae; Carole Ober
Journal:  Respir Res       Date:  2003-12-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.